Aimmune Therap (AIMT) Stock Analyst Ratings
NASDAQ:AIMT - Nasdaq -
ChartMill assigns a Buy % Consensus number of 73% to AIMT. The Buy consensus is the weighted average rating of the current analysts ratings.
AIMT was analyzed by 9 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about AIMT.
In the previous month the buy percentage consensus was at a similar level.
AIMT was analyzed by 9 analysts. More opinions would make the average more meaningful.